Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Pharmalot
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Gottlieb’s pledge to uphold ‘gold standard’ raises red flags

  • Meghana Keshavan

By Meghana Keshavan April 5, 2017

Reprints
Scott Gottlieb
Dr. Scott Gottlieb. Chip East/Reuters

When Dr. Scott Gottlieb pledged at his confirmation hearing to uphold a “gold standard of safety and efficacy” at the Food and Drug Administration, he raised an important question:

What exactly does he mean by that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Stanford scientist who broke genome sequencing record on what…
Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients
Denied by AI: How Medicare Advantage plans use algorithms…
Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in…
When women are denied an abortion, their children fare…
When women are denied an abortion, their children fare worse than peers
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug
Pharmalittle: FDA panel backs conditional approval for Biogen ALS…
Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty…
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’…
Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs

Comments are closed.

Recommended Stories